secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2024-01-17T23:59:59+00:00
Accession:  0001628280-24-001504
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics appoints Stephen J. DiPalma as interim CFO and Treasurer, effective Jan 16, 2024
--------------------------------------------------------------------------------

- Stephen J. DiPalma appointed as Treasurer and interim CFO, effective immediately.
- Company continues search for a permanent CFO; DiPalma is a managing director at Danforth Advisors.
- Foghorn will pay Danforth an agreed hourly rate plus expenses for DiPalma's interim CFO services.
- DiPalma has served as CFO to multiple public and private life sciences companies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024001504/0001628280-24-001504-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024001504/fhtx-20240116.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-001504

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer